ASCO GI

1 stories · following the connections

Business

OncoMed Presents Updated Phase 1b Data for Demcizumab in First-Line Pancreatic Cancer at the Gastrointestinal Cancers Symposium

By Nasdaq OMXJan 22, 2016, 1:30 PM UTC